Time's running short on my prediction of news. I still have faith the company will release something significant prior to or at the ISOBM conference. My guess is it will be some sort of clinically oriented news...like more data. Maybe, just maybe, it involves Goshen. Or maybe, just maybe, it involves SOMETHING DIFFERENT from past clinical trial data that, while significant, has been rightfully considered by the market to be prelminary and unverified.
A company that trades on the pinks, was formed with a reverse merger into a bulletin board shell, and has had SEC issues will not be taken seriously when it releases unverified internal data. As BOCX longs we know that first hand! If they release some fresh data for the ISOBM I hope there is SOMETHING DIFFERENT...not just more of the same.
DISCLAIMER: NEVER ASSUME INFO ON MESSAGE BOARDS TO BE ACCURATE. ALWAYS DO YOUR OWN DUE DILIGENCE. DON'T BUY STOCK BASED ON THIS POST OR ANY OTHER POST. I OWN A LONG POSITION IN THIS STOCK AND THEREFORE I AM BIASED.
